Skip to main content

Inhibin, Activin, and Follistatin: Observations on Their Role in the Physiology of Pregnancy

  • Chapter
Inhibin, Activin and Follistatin

Abstract

Following the isolation of inhibin A and B and activins A, AB, and B (1–4), a large number of studies have defined a variety of physiological roles for these subtances that range well beyond their ability to suppress or stimulate follicle-stimulating hormone (FSH) secretion. Using radioimmunoassays that have now been shown to detect not only dimeric inhibin but products of the α-subunit, changes in inhibin secretion have been identified in a variety of pathophysiological states related to pregnancy. Following the demonstration that the human corpus luteum secreted both dimeric inhibin and free α-sub-unit products (5, 6), inhibin levels were shown to rise in conception cycles in contrast to the declining levels in nonpregnant cycles (7). Several studies have demonstrated that serum inhibin in pregnancy rose during the first trimester, plateaued in the second trimester, and rose again in the third trimester (8–11).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Robertson DM, Foulds LM, Leversha L, Morgan FJ, Hearn MTW, Burger HG, et al. Isolation of inhibin from bovine follicular fluid. Biochem Biophys Res Commun 1985;126:220–6.

    Article  PubMed  CAS  Google Scholar 

  2. Ling N, Ying SY, Ueno N, Esch F, Denoray L, Guillemin R. Isolation and partial characterization of a Mw 32,000 protein with inhibin activity from porcine follicular fluid. Proc Natl Acad Sci USA 1985;82:7217–21.

    Article  PubMed  CAS  Google Scholar 

  3. Ling N, Ying SY, Ueno N, Shimasaki S, Esch F, Hotta M, et al. Pituitary FSH is released by a heterodimer of the β subunits of the two forms of inhibin. Nature (Lond) 1986;321:779–82.

    Article  CAS  Google Scholar 

  4. Vale W, Rivier J, Vaughan J, McClintock R, Corrigan A, Woo W, et al. Purification and characterization of an FSH releasing protein from porcine follicular fluid. Nature (Lond) 1986;321:776–9.

    Article  CAS  Google Scholar 

  5. McLachlan RI, Robertson DM, Healy DL, Burger HG, de Kretser DM. Circulating immunoreactive inhibin levels during the normal menstrual cycle. J Clin Endocrinol Metab 1987;65:954–61.

    Article  PubMed  CAS  Google Scholar 

  6. Groome NP, Illingworth PJ, O’Brien M, Cooke I, Ganesan TS, Baird DT, et al. Detection of dimeric inhibin throughout the inhibin menstrual cycle by two-site enzyme immunoassay. Clinical Endocrinol 1994;40:717–23.

    Article  CAS  Google Scholar 

  7. Lenton AE, de Kretser DM, Woodward A. Inhibin concentrations throughout the menstrual cycle in normal infertile and elderly women in comparison with profiles from spontaneous conception cycles. J Clin Endocrinol 1991;73:1180–90.

    Article  CAS  Google Scholar 

  8. Abe Y, Hasegawa Y, Miyamoto K, Yamaguchi M, Andoh A, Ibuki Y, et al. High concentrations of plasma immunoreactive inhibin during normal pregnancy in women. J Clin Endocrinol Metab 1990;71:133–7.

    Article  PubMed  CAS  Google Scholar 

  9. Yohkaichiya T, Poison D, O’Connor A, Bishop S, Mamers P, McLachlan V, et al. Concentrations of immunoactive inhibin in serum during human pregnancy: evidence for an ovarian contribution. Reprod Fertil Dev 1991;3:671–8.

    Article  PubMed  Google Scholar 

  10. Tabei T, Ochiai K, Terashima Y, Takanashi N. Serum levels of inhibin in maternal and umbilical blood during pregnancy. Am J Obstet Gynecol 1991;164:896–900.

    PubMed  CAS  Google Scholar 

  11. Tovanabutra S, Illingworth PJ, Ledger WL, Glasier AF, Baird DT. The relationship between peripheral immunoreactive inhibin, human chorionic gonadotrophin, oestra-diol and progesterone during human pregnancy. Clin Endocrinol 1993;38:101–7.

    Article  CAS  Google Scholar 

  12. Yohkaichiya T, Poison D, McLachlan V, Healy DL, de Kretser DM. Serum immunoreactive inhibin levels in early pregnancy following in vitro fertilization and embryo transfer: evidence for an ovarian source of inhibin and assessment of the value of inhibin measurements in predicting outcome of pregnancy. Fertil Steril 1993;5:1081–9.

    Google Scholar 

  13. McLachlan RI, Healy DL, Robertson DM, Burger HG, de Kretser DM. The human placenta: A novel source of inhibin. Biophys Biochem Res Commun 1986;48:51–8.

    Google Scholar 

  14. Petraglia F, Sawchenko P, Lim ATW, Rivier J, Vale W. Localisation, secretion and action of inhibin in human placenta. Science 1987;237:187–9.

    Article  PubMed  CAS  Google Scholar 

  15. Muttukrishna S, George L, Fowler PA, Groome NP, Knight PG. Measurement of serum concentrations of inhibin A (α-βa dimer) during human pregnancy. Clin Endocrinol 1995;42:391–7.

    Article  CAS  Google Scholar 

  16. Tuuri T, Eramaa M, Hilden K, Ritves O. The tissue distribution of activin βa and βB-subunits and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. J Clin Endocrinol Metab 1994;78:1521–4.

    Article  PubMed  CAS  Google Scholar 

  17. Woodruff TK, Mather JP. Inhibin, activin and the female reproductive axis. Annu Rev Physiol 1995;57:219–44.

    Article  PubMed  CAS  Google Scholar 

  18. Robertson DM, Klein R, de Vos FL, McLachlan RI, Wettenhall REH, Hearn MTW, et al. The isolation of polypeptides with FSH suppressing activity from bovine follicular fluid which are structurally different to inhibin. Biochem Biophys Res Commun 1987;149:744–9.

    Article  PubMed  CAS  Google Scholar 

  19. Ueno N, Ling N, Ying S, Esch F, Shimasaki S, Guillemin R. Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle stimulating hormone. Proc Natl Acad Sci USA 1987;84:8282–6.

    Article  PubMed  CAS  Google Scholar 

  20. Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H. Activin-binding protein from rat ovary is follistatin. Science 1990;247:836–8.

    Article  PubMed  CAS  Google Scholar 

  21. Wong W, Garg S, Bald L, Fendly B, Woodruff T, Lofgren J. Monoclonal antibody based ELIS As for measurement of activins in biological fluids. J Immunol Methods 1993;165:1–10.

    Article  PubMed  CAS  Google Scholar 

  22. Knight PG, Muttukrishna S, Groome NP. Development and application of a two-site enzyme immunoassay for determination of‘total’ activin A concentrations in serum and follicular fluid. J Endocrinol 1996;148:267–79.

    Article  PubMed  CAS  Google Scholar 

  23. Robertson DM, Foulds LM, Prisk M, Hedger MP. Inhibin/activin β subunit monomer: isolation and characterization. Endocrinology 1992;130:1680–7.

    Article  PubMed  CAS  Google Scholar 

  24. de Kretser DM, Foulds LM, Hancock M, Robertson DM. Partial characterisation of inhibin, activin and follistatin in the term human placenta. J Clin Endocrinol Metab 1994;79:502–7.

    Article  PubMed  Google Scholar 

  25. McFarlane JR, Fouls LM, Pisciotta A, Robertson DM, de Kretser DM. Measurement of activin in biological fluids by radioimmunoassay, utilizing dissociating agents to remove the interference of follistatin. Eur J Endocrinol 1996;134:481–9.

    Article  PubMed  CAS  Google Scholar 

  26. Klein R, Findlay JK, Clarke IJ, de Kretser DM, Robertson DM. Radioimmunoassay of plasma FSH-suppressing protein/follistatin in the ewe: concentrations during the estrous cycle and following ovariectomy and PMSG stimulation. J Endocrinol 1993;137:433–43.

    Article  PubMed  CAS  Google Scholar 

  27. Petraglia F, Garuti CG, Calza L, Roberts V, Giardino L, Genazzani AR, et al. Inhibin subunits in human placenta: localisation and messenger ribonucleic acid levels during pregnancy. Am J Obstet Gynecol 1991;165:750–8.

    PubMed  CAS  Google Scholar 

  28. Minami S, Yamoto M, Nakamo R. Immunohistochemical localisation of inhibin/ activin subunits in human placenta. Obstet Gynecol 1992;80:410–4.

    PubMed  CAS  Google Scholar 

  29. Rabinovici J, Goldsmith PC, Librach CL, Jaffe RB. Localisation and regulation of the activin A dimer in human placental cells. J Clin Endocrinol Metab 1992;75:571–6.

    Article  PubMed  CAS  Google Scholar 

  30. Hotten G, Neidhardt H, Schneider C, Pohl J. Cloning of a new member of the TGFβ family: a putative new activin βc chain. Biochem Biophys Res Commun 1995;206:608–13.

    Article  Google Scholar 

  31. Oda S, Nishimatsu S, Murakani K, Ueno N. Molecular cloning and functional analysis of a new activin beta subunit: a dorsal mesoderm-inducing activity in Xenopus. Biochem Biophys Res Commun 1995;210:581–8.

    Article  PubMed  CAS  Google Scholar 

  32. Loveland KL, McFarlane JR, de Kretser DM. Expression of βc subunit mRNA in reproductive tissues. J Mol Endocrinol 1996;17:61–5.

    Article  PubMed  CAS  Google Scholar 

  33. Yokoyama Y, Nakamura T, Nakamura R, Irahara M, Aono T, Sugino H. Identification of activins and follistatin proteins in human follicular fluid and placenta. J Clin Endocrinol Metab 1995;80:915–21

    Article  PubMed  CAS  Google Scholar 

  34. Petraglia F, Gallinelli A, Grande A, Florio P, Ferrari S, Genazzani AR, et al. Local production and action of follistatin in human placenta. J Clin Endocrinol Metab 1994;78:205–10.

    Article  PubMed  CAS  Google Scholar 

  35. Petraglia F, Vaughan J, Vale W. Inhibin and activin modulate the release of gona-dotropin-releasing hormone, human chorionic gonadotrophin and progesterone from cultured human placental cells. Proc Natl Acad Sci USA 1989;86:5114–7.

    Article  PubMed  CAS  Google Scholar 

  36. Steele GL, Currie WD, Yuen BH, Xiao-Chi J, Perlas E, Leung PCK. Acute stimulation of human chorionic gonadotropin secretion by recombinant human activin A in first trimester human trophoblast. Endocrinology 1993;133:297–303.

    Article  PubMed  CAS  Google Scholar 

  37. Hedger MP, Drummond AE, Robertson DM, Risbridger GP, de Kretser DM. Inhibin and activin regulate 3H-thymidine uptake by rat thymocytes and 3T3 in vitro. Mol Cell Endocrinol 1989;61:133–8.

    Article  PubMed  CAS  Google Scholar 

  38. Petraglia F, Garg S, Florio P, Sadick M, Gallinelli A, Wong WL, et al. Activin A and activin B measured in maternal serum, cord blood serum and amniotic fluid during human pregnancy. Endocrinol J 1993;1:323–7.

    Google Scholar 

  39. Wongprasartsuk S, Jenkin G, McFarlane JR, Goodman M, de Kretser DM. Inhibin, follistatin and activin concentrations in fetal tissues and fluids during gestation in sheep. J Endocrinol 1994;141:219–29.

    Article  PubMed  CAS  Google Scholar 

  40. de Kretser DM, Foulds LM, Hancock M, McFarlane JR, Goss N, Jenkin G. The isolation of activin from ovine amniotic fluid. Endocrinology 1994;134:1231–7.

    Article  PubMed  Google Scholar 

  41. Petraglia F, Gallinelli A, de Vita D, Lewis K, Mathews L, Vale W. Activin at parturition: changes of maternal serum levels and evidence for binding sites in placenta and fetal membranes. Obstet Gynecol 1994;84:278–82.

    PubMed  CAS  Google Scholar 

  42. Roberts VJ, Sawchenko PE, Vale WW. Expression of inhibin/activin subunit messenger ribonucleic acids during rat embryogenesis. Endocrinology 1990;128:3122–9.

    Article  Google Scholar 

  43. Rabinovici J, Goldsmith PC, Roberts VJ, Vaughan J, Vale W, Jaffe RB. Localisation and secretion of inhibin/activin subunits in the human and subhuman primate fetal gonads. J Clin Endocrinol Metab 1991;73:1141–9.

    Article  PubMed  CAS  Google Scholar 

  44. Petraglia F, Aneeschi MM, Calza L, Garuti GC, Fusaro P, Giardino L, et al. Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release. J Clin Endocrinol Metab 1993;77:542–8.

    Article  PubMed  CAS  Google Scholar 

  45. Petraglia F, de Vita D, Gallinelli A, Lorenzo A, Genazzani AR, Romero R, et al. Abnormal concentrations of maternal serum activin A in gestational diseases. J Clin Endocrinol Metab 1995;80:558–61.

    Article  PubMed  CAS  Google Scholar 

  46. Wakatsuki M, Shintani Y, Abe M, Liu Z, Shitsukawa K, Saito S. Immunoradiometric assay for follistatin: serum immunoreactive follistatin levels in normal adults and pregnant women. J Clin Endocrinol Metab 1996;81:630–4.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media New York

About this chapter

Cite this chapter

De Kretser, D.M. et al. (1997). Inhibin, Activin, and Follistatin: Observations on Their Role in the Physiology of Pregnancy. In: Aono, T., Sugino, H., Vale, W.W. (eds) Inhibin, Activin and Follistatin. Serono Symposia USA. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-1874-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-1874-6_8

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7320-2

  • Online ISBN: 978-1-4612-1874-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics